NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.70
−0.40%Next report
Analyst consensus
- Next report date
- Oct 5, 2026
- EPS estimate
- -$1.58
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 18, 2026
- EPS actual
- -$0.56
- EPS estimate
- -$0.56
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -388.0%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 18, 2026 | -$0.56 | -$0.56 | In line | — |
| May 15, 2026 | -$0.56 | -$0.09 | Beat 83.93% | — |
| Nov 14, 2025 | -$0.55 | -$4.41 | Miss -701.82% | — |
| Sep 29, 2025 | -$0.56 | -$5.79 | Miss -933.93% | -$15.7M |
| May 20, 2025 | -$0.47 | $6.55 | Beat 1493.62% | — |
| Mar 17, 2025 | -$2.01 | -$0.01 | Beat 99.59% | $662.6K |
| Nov 14, 2024 | — | -$0.00 | — | — |
| Sep 30, 2024 | -$11 | -$29 | Miss -156.21% | — |
| Mar 30, 2024 | — | -$0.02 | — | -$79.0K |
| Dec 31, 2023 | — | -$0.03 | — | — |
| Sep 30, 2023 | -$13 | -$0.01 | Beat 99.96% | $5.5M |
| Feb 22, 2023 | -$15 | -$18 | Miss -15.30% | $214.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 5, 2026